National Opioids Settlements – Information for Georgia Cities and Counties
This page provides information for Georgia cities and counties regarding the National Opioids Settlements, including multistate settlements with various pharmaceutical distributors, manufacturers, and pharmacies.
Walmart, CVS, Walgreens, Teva and Allergan Settlements
The proposed multistate settlement with Walmart was announced by Attorney General Chris Carr on December 19, 2022, and the proposed multistate settlements with CVS, Walgreens, Teva and Allergan that were announced by Attorney General Carr on January 5, 2023.
Copies of the settlements can be viewed at nationalopioidsettlement.com.
Participation Forms were sent out on February 1, 2023 to each Georgia local government that is eligible to participate in a settlement. The Participation Form for each settlement must be executed, without alteration, and submitted before April 18, 2023, in order for your subdivision to be considered an “Initial Participating Subdivision.” After April 18th, the subdivision participation rate will be used to determine whether participation for each deal is sufficient for the settlement to move forward and whether a state earns its maximum potential payment under the settlement. If the settlement moves forward, your release will become effective. If a settlement does not move forward, that release will not become effective.
Any subdivision that does not participate cannot directly share in the settlement funds, even if the subdivision’s state is settling and other participating subdivisions are sharing in settlement funds. Any subdivision that does not participate may also reduce the amount of money for programs to remediate the opioid crisis in its state. Please note, a subdivision will not necessarily directly receive settlement funds by participating.
For questions regarding sign-on to the settlements, cities and counties may contact the Implementation Administrator at [email protected].
McKesson, Cardinal Health and AmerisourceBergen (the Distributors) and Johnson & Johnson Settlements
The multistate settlements with McKesson, Cardinal Health and AmerisourceBergen (the Distributors), and manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson (collectively J&J), which were announced by Attorney General Chris Carr on January 7, 2022, provide substantial funds for the abatement of the opioid epidemic in Georgia and throughout the United States, and they require changes in the way that the settling defendants conduct their business. Copies of the Distributors and J&J settlement documents are linked below:
Additional information regarding these settlements is available at https://nationalopioidsettlement.com.
Georgia and a group of cities and counties reached agreement on an allocation of recoveries that Georgia will receive pursuant to the Distributors and J&J settlements.
We understand that some Cities and Counties have already started receiving funds from the Distributors and J&J settlements and may have questions about the restrictions which govern how these funds may be used. We encourage local governments to visit our “Guidance on Opioid Settlement Fund Usage” page, which provides guidance and links to documents that stipulate how these funds may be used.
For questions regarding sign-on to the settlements, cities and counties may contact the National Settlement Administrator at [email protected].